SABS SAB Biotherapeutics Inc
Company Analysis
Latest News
🟢 SAB Biotherapeutics is trading 5.8% up in pre-market — reason remains unclear
SAB Biotherapeutics is trading at $2.74, up 5.79% in pre-market; the reason for the move remains unclear. - No October 16 company-specific catalyst was...
🔴 SAB Biotherapeutics is trading 5% down today; no clear company-specific catalyst reported
SAB Biotherapeutics is trading at $2.54, down 5.04%, with no clear company-specific catalyst reported. - October 13: FDA granted Fast Track designation for...
🟢 SAB Biotherapeutics is trading 8.8% up in pre-market
SAB Biotherapeutics is trading at $2.91, up 8.76% in pre-market; no clear reported catalyst for the rise was found. - The previous close was $2.68; supplied...
🔴 SAB Biotherapeutics is trading 5.5% down today amid biotech-sector weakness
SAB Biotherapeutics is trading at $2.67, down -5.48%, with biotech-sector weakness the clearest matching context. - The XBI is down 2.01% during the regular...
SABS Receives FDA Fast Track Designation for Type 1 Diabetes Therapy SAB-142
SAB Biotherapeutics announced it has received Fast Track designation from the U.S. Food and Drug Administration (FDA) for its lead candidate, SAB-142. The...
🔴 SAB Biotherapeutics is trading 5% down; no specific catalyst identified
SAB Biotherapeutics is trading at $2.83, down 5.03%; no confirmed company-specific announcement explains the October 12 decline. - The latest identified...
🟢 SAB Biotherapeutics is trading 7.61% up in pre-market with no confirmed catalyst
SAB Biotherapeutics is trading at $3.11, up 7.61%, in pre-market, with no fresh company-specific announcement identified to explain the gain. - The company...
🔴 SAB Biotherapeutics is trading 5% down in pre-market
SAB Biotherapeutics is trading at $2.74, with a -5.19% move in pre-market and no clear catalyst identified. - No fresh company-specific announcement...
🔴 SAB Biotherapeutics is trading 7.6% down in pre-market with no clear company-specific catalyst identified
SAB Biotherapeutics is trading at $2.66, down 7.64% versus the October 7 close, with no clear company-specific catalyst identified for the October 8 pre-market...
🟢 SAB Biotherapeutics is trading 9.2% up in after-hours trading — catalyst remains unclear
SAB Biotherapeutics is trading at $3.20, up 9.22%, as the cause of the October 6 after-hours rise remains unclear. - The latest company release, dated October...
🔴 SAB Biotherapeutics is trading 5% down today with biotech-sector weakness the likeliest context
SAB Biotherapeutics is trading at $2.94, down 5.16%, with biotech-sector weakness the likeliest context; available evidence does not establish a direct...
🟢 SAB Biotherapeutics is trading 5.7% up with no confirmed catalyst
SAB Biotherapeutics is trading 5.7% higher at $3.15, with no confirmed company-specific catalyst identified for October 5, 2026. - The latest company...
🟢 SAB Biotherapeutics is trading 9.4% up in pre-market with no confirmed fresh catalyst
SAB Biotherapeutics is trading 9.4% up in pre-market at $3.26 on October 5, 2026, versus its October 2 close of $2.98; no fresh catalyst has been confirmed. -...